Kynam Capital Management, LP Biocryst Pharmaceuticals Inc Put Options Transaction History
Kynam Capital Management, LP
- $837 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BCRX
# of Institutions
315Shares Held
202MCall Options Held
928KPut Options Held
560K-
Vanguard Group Inc Valley Forge, PA20.5MShares$172 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$167 Million0.0% of portfolio
-
State Street Corp Boston, MA8.51MShares$71 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY5.71MShares$47.7 Million0.09% of portfolio
-
Ubs Group Ag5.61MShares$46.9 Million0.01% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.55B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...